Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
1 Introduction Metastatic castration-resistant prostate cancer (mCRPC) remains largely unresponsive to multiple treatment interventions despite clinical advancements, although the overall fatality rate arising from prostate cancer has declined in developed nations [1]. Alarmingly, a global rise in prostate cancer incidence and its progression towards mCRPC is being observed [2].
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
